Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Lancet Oncol. 2013 Jul 1;14(9):863–872. doi: 10.1016/S1470-2045(13)70255-9

Table 1. Baseline characteristics.

Paclitaxel group (n=46) Fluorouracil group (n=47)
Age, years 65 (48–82; 60–73) 67 (44–83; 61–74)

Sex
 Male 38 (83%) 40 (85%)
 Female 8 (17%) 7 (15%)

Zubrod performance status
 0 42 (91%) 42 (89%)
 1 4 (9%) 5 (11%)

Tumour stage
 T2 44 (96%) 44 (94%)
 T3–4 2 (4%) 3 (6%)

Data are median (range; IQR) or n (%).